Investigation of the Active Ingredients and Mechanism of Hudi Enteric-Coated Capsules in DSS-Induced Ulcerative Colitis Mice Based on Network Pharmacology and Experimental Verification

References

• Lloyd-PriceJ, ArzeC, AnanthakrishnanAN, et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature. 2019;569(7758):655–662. doi:10.1038/s41586-019-1237-931142855
   PubMed Web of Science ®Google Scholar
• de SouzaHS, FiocchiC. Immunopathogenesis of IBD: current state of the art. Nat Rev Gastroenterol Hepatol. 2016;13(1):13–27. doi:10.1038/nrgastro.2015.18626627550
   PubMed Web of Science ®Google Scholar
• UngaroR, MehandruS, AllenPB, Peyrin-BirouletL, ColombelJF. Ulcerative colitis. Lancet. 2017;389(10080):1756–1770. doi:10.1016/S0140-6736(16)32126-227914657
   PubMed Web of Science ®Google Scholar
• HibiT, OgataH. Novel pathophysiological concepts of inflammatory bowel disease. J Gastroenterol. 2006;41(1):10–16. doi:10.1007/s00535-005-1744-316501852
   PubMed Web of Science ®Google Scholar
• HallingML, KjeldsenJ, KnudsenT, NielsenJ, HansenLK. Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases. World J Gastroenterol. 2017;23(33):6137–6146. doi:10.3748/wjg.v23.i33.613728970729
   PubMed Web of Science ®Google Scholar
• NgSC, ShiHY, HamidiN, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390(10114):2769–2778. doi:10.1016/S0140-6736(17)32448-029050646
   PubMed Web of Science ®Google Scholar
• LiR, ChenY, ShiM, et al. Gegen Qinlian decoction alleviates experimental colitis via suppressing TLR4/NF-κB signaling and enhancing antioxidant effect. Phytomedicine. 2016;23(10):1012–1020. doi:10.1016/j.phymed.2016.06.01027444346
   PubMed Web of Science ®Google Scholar
• MaQ, OuyangY, MengF, et al. A review of pharmacological and clinical studies on the application of Shenling Baizhu San in treatment of ulcerative colitis. J Ethnopharmacol. 2019;244:112105. doi:10.1016/j.jep.2019.11210531344480
   PubMed Web of Science ®Google Scholar
• LuoS, WenR, WangQ, et al. Rhubarb Peony decoction ameliorates ulcerative colitis in mice by regulating gut microbiota to restoring Th17/Treg balance. J Ethnopharmacol. 2019;231:39–49. doi:10.1016/j.jep.2018.08.03330170079
   PubMed Web of Science ®Google Scholar
• ZhaoY, LuanH, GaoH, WuX, ZhangY, LiR. Gegen Qinlian decoction maintains colonic mucosal homeostasis in acute/chronic ulcerative colitis via bidirectionally modulating dysregulated Notch signaling. Phytomedicine. 2020;68:153182. doi:10.1016/j.phymed.2020.15318232065953
   PubMed Web of Science ®Google Scholar
• ShenH, ZhuL, HuN, et al. Hudi enteric-coated capsule combined with Mesalazine enteric-coated tablet for active ulcerative colitis: a multi-centre, randomized, double-blinded and double-simulated clinical study. Chin J Tradit West Med. 2019;39(11):1326–1331.
   Google Scholar
• HopkinsAL. Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol. 2008;4(11):682–690. doi:10.1038/nchembio.11818936753
   PubMed Web of Science ®Google Scholar
• LiS, ZhangB. Traditional Chinese medicine network pharmacology: theory, methodology and application. Chin J Nat Med. 2013;11(2):110–120. doi:10.3724/SP.J.1009.2013.0011023787177
   PubMed Web of Science ®Google Scholar
• RuJ, LiP, WangJ, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 2014;6(1):13. doi:10.1186/1758-2946-6-1324735618
   PubMed Web of Science ®Google Scholar
• StelzerG, DalahI, SteinTI, et al. In-silico human genomics with GeneCards. Hum Genomics. 2011;5(6):709–717. doi:10.1186/1479-7364-5-6-70922155609
   PubMedGoogle Scholar
• AmbergerJS, BocchiniCA, SchiettecatteF, ScottAF, HamoshA. OMIM.org: Online Mendelian Inheritance In Man (OMIM(R)), an online catalog of human genes and genetic disorders. Nucleic Acids Res. 2015;43(D1):D789–798. doi:10.1093/nar/gku120525428349
   PubMed Web of Science ®Google Scholar
• PineroJ, BravoA, Queralt-RosinachN, et al. DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants. Nucleic Acids Res. 2017;45(D1):D833–D839. doi:10.1093/nar/gkw94327924018
   PubMed Web of Science ®Google Scholar
• SzklarczykD, FranceschiniA, WyderS, et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015;43(D1):D447–452. doi:10.1093/nar/gku100325352553
   PubMed Web of Science ®Google Scholar
• LiuB, LiS, SuiX, et al. Root extract of Polygonum cuspidatum Siebold & Zucc. Ameliorates DSS-induced ulcerative colitis by affecting nf-kappab signaling pathway in a mouse model via synergistic effects of polydatin, resveratrol, and emodin. Front Pharmacol. 2018;9:34729695964
   PubMed Web of Science ®Google Scholar
• MaJ, YinG, LuZ, et al. Casticin prevents DSS induced ulcerative colitis in mice through inhibitions of NF-κB pathway and ROS signaling. Phytother Res. 2018;32(9):1770–1783. doi:10.1002/ptr.610829876982
   PubMed Web of Science ®Google Scholar
• MurthySN, CooperHS, ShimH, ShahRS, IbrahimSA, SedergranDJ. Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. Dig Dis Sci. 1993;38(9):1722–1734. doi:10.1007/BF013031848359087
   PubMed Web of Science ®Google Scholar
• LiX, LiuY, WangY, et al. Sucralose promotes colitis-associated colorectal cancer risk in a murine model along with changes in microbiota. Front Oncol. 2020;10:710. doi:10.3389/fonc.2020.0071032582527
   PubMed Web of Science ®Google Scholar
• GuoT, LinQ, LiX, et al. Octacosanol attenuates inflammation in both RAW264.7 macrophages and a mouse model of colitis. J Agric Food Chem. 2017;65(18):3647–3658. doi:10.1021/acs.jafc.6b0546528122452
   PubMed Web of Science ®Google Scholar
• LiuCS, XiaT, LuoZY, et al. Network pharmacology and pharmacokinetics integrated strategy to investigate the pharmacological mechanism of Xianglian pill on ulcerative colitis. Phytomedicine. 2021;82:153458. doi:10.1016/j.phymed.2020.15345833486267
   PubMed Web of Science ®Google Scholar
• SoufliI, ToumiR, RafaH, Touil-BoukoffaC. Overview of cytokines and nitric oxide involvement in immuno-pathogenesis of inflammatory bowel diseases. World J Gastrointest Pharmacol Ther. 2016;7(3):353–360. doi:10.4292/wjgpt.v7.i3.35327602236
   PubMedGoogle Scholar
• KatsanosKH, PapadakisKA. Inflammatory bowel disease: updates on molecular targets for biologics. Gut Liver. 2017;11(4):455–463. doi:10.5009/gnl1630828486793
   PubMed Web of Science ®Google Scholar
• RossettiS, ActisGC, FaddaM, RizzettoM, PalmoA. The use of the anti-tumour necrosis factor monoclonal antibody—infliximab—to treat ulcerative colitis: implications and trends beyond the available data. Digest Liver Dis. 2004;36(6):426–431. doi:10.1016/S1590-8658(04)00088-X
   Web of Science ®Google Scholar
• CocciaM, HarrisonOJ, SchieringC, et al. IL-1β mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4+ Th17 cells. J Exp Med. 2012;209(9):1595–1609. doi:10.1084/jem.2011145322891275
   PubMed Web of Science ®Google Scholar
• DinarelloCA. Biologic basis for interleukin-1 in disease. Blood. 1996;87(6):2095–2147. doi:10.1182/blood.V87.6.2095.bloodjournal87620958630372
   PubMed Web of Science ®Google Scholar
• SimonLS. Role and regulation of cyclooxygenase-2 during inflammation. Am J Med. 1999;106(5B):37S–42S. doi:10.1016/S0002-9343(99)00115-110390126
   PubMedGoogle Scholar
• PaiottiAP, MarchiP, MiszputenSJ, OshimaCT, FrancoM, RibeiroDA. The role of nonsteroidal antiinflammatory drugs and cyclooxygenase-2 inhibitors on experimental colitis. In Vivo. 2012;26(3):381–393.22523290
   PubMed Web of Science ®Google Scholar
• MartinAR, VillegasI, Alarcón de la LastraC. The COX-2 inhibitor, rofecoxib, ameliorates dextran sulphate sodium induced colitis in mice. Inflamm Res. 2005;54(4):145–151. doi:10.1007/s00011-004-1337-215883736
   PubMed Web of Science ®Google Scholar
• de FariaFM, Luiz-FerreiraA, SoccaEA, et al. Effects of Rhizophora mangle on experimental colitis induced by TNBS in rats. Evid Based Complement Alternat Med. 2012;2012:753971. doi:10.1155/2012/75397123056142
   PubMed Web of Science ®Google Scholar
• LiY, SoendergaardC, BergenheimFH, et al. COX-2-PGE2 signaling impairs intestinal epithelial regeneration and associates with TNF inhibitor responsiveness in ulcerative colitis. EBioMedicine. 2018;36:497–507. doi:10.1016/j.ebiom.2018.08.04030190207
   PubMed Web of Science ®Google Scholar
• MajumderS, AmatyaN, RevuS, et al. IL-17 metabolically reprograms activated fibroblastic reticular cells for proliferation and survival. Nat Immunol. 2019;20(5):534–545. doi:10.1038/s41590-019-0367-430962593
   PubMed Web of Science ®Google Scholar
• SinghAK, KhareP, ObaidA, et al. SUMOylation of ROR-γt inhibits IL-17 expression and inflammation via HDAC2. Nat Commun. 2018;9(1):4515. doi:10.1038/s41467-018-06924-530375383
   PubMed Web of Science ®Google Scholar
• RampalR, PhdN, SinghA, et al. Retinoic acid is elevated in the mucosa of patients with active ulcerative colitis and displays a proinflammatory role by augmenting IL-17 and IFNγ production. Inflamm Bowel Dis. 2020;27(1):74–83.
   Web of Science ®Google Scholar
• SalasA, Hernandez-RochaC, DuijvesteinM, et al. JAK–STAT pathway targeting for the treatment of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2020;17(6):323–337. doi:10.1038/s41575-020-0273-032203403
   PubMed Web of Science ®Google Scholar
• LinH, HonglangL, WeifengL, JunminC, JiantaoY, JunjingG. The mechanism of alopolysaccharide protecting ulceralive colitis. Biomed Pharmacother. 2017;88:145–150. doi:10.1016/j.biopha.2016.11.13828103508
   PubMed Web of Science ®Google Scholar
• ChuXQ, WangJ, ChenGX, ZhangGQ, ZhangDY, CaiYY. Overexpression of microRNA-495 improves the intestinal mucosal barrier function by targeting STAT3 via inhibition of the JAK/STAT3 signaling pathway in a mouse model of ulcerative colitis. Pathol Res Pract. 2018;214(1):151–162. doi:10.1016/j.prp.2017.10.00329129493
   PubMed Web of Science ®Google Scholar
• VavrickaSR, GalvanJA, DawsonH, et al. Expression patterns of TNFα, MAdCAM1, and STAT3 in intestinal and skin manifestations of inflammatory bowel disease. J Crohns Colitis. 2018;12(3):347–354. doi:10.1093/ecco-jcc/jjx15829182760
   PubMed Web of Science ®Google Scholar
• YuT, LiZ, XuL, YangM, ZhouX. Anti-inflammation effect of Qingchang suppository in ulcerative colitis through JAK2/STAT3 signaling pathway in vitro and in vivo. J Ethnopharmacol. 2021;266:113442. doi:10.1016/j.jep.2020.11344233027643
   PubMed Web of Science ®Google Scholar
• GurungP, DahalS, ChaudharyP, et al. Potent inhibitory effect of BJ-3105, a 6-Alkoxypyridin-3-ol derivative, on murine colitis is mediated by activating AMPK and inhibiting NOX. Int J Mol Sci. 2020;21(9):3145. doi:10.3390/ijms21093145
   Web of Science ®Google Scholar